Mesh : Anti-Bacterial Agents / therapeutic use Chlamydophila pneumoniae Community-Acquired Infections / diagnosis drug therapy microbiology Humans Intensive Care Units Legionella pneumophila Pneumonia, Bacterial / diagnosis drug therapy microbiology Practice Guidelines as Topic Prevalence Pseudomonas aeruginosa Streptococcus pneumoniae Treatment Outcome

来  源:   DOI:10.1097/00075198-200402000-00010   PDF(Sci-hub)

Abstract:
Community-acquired pneumonia remains a common and serious condition worldwide. Severe community-acquired pneumonia requiring ICU admission is a distinct entity with different pathogens, outcomes, and management. The mortality rate in severe community-acquired pneumonia can be more than 50%. Over the past decade, some international guidelines for the management of community-acquired pneumonia have been developed in an attempt to optimize patient care. These guidelines have developed prediction tools to direct clinicians in the management of community-acquired pneumonia, including when to admit a patient to the ICU and selecting appropriate investigations and antimicrobial therapy. The individual recommendations of these guidelines and the guidelines as a whole require further studies.
摘要:
暂无翻译
公众号